Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06607731

Percutaneous Gelled Alcohol Sclerotherapy for Aggressive Angiomas: Evaluation of Feasibility, Safety, and Efficacy

The investigators aimed to evaluate efficacy and safety of a non-surgical protocol treatment combining transarterial embolization and percutaneous radiopaque gelled ethanol (RGE) sclerotherapy in a first procedure, then followed by vertebroplasty in a second procedure, to treat aggressive vertebral hemangioma patients in tertiary hospital. Exclusion criteria were age <18-years old and any association with neurological deficit.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Bone Angioma

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Saint-Etienne

Saint-Priest-en-Jarez, 42270, France

Location status: Recruiting

Location contact

Sylvain Grange, MD

CONTACT

[email protected]

(0)477829066 ext. +33

Sylvain Grange, MD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Every patients treated by gelled alcohol sclerotherapy for aggressive angiomas, in the University Hospital of Saint-Etienne.

Exclusion criteria

  • Patients no treated by gelled alcohol sclerotherapy.

Treatment and study plan

Collecting data from medical records

Other

Data collected: clinical data (particularly pain), biological data, imaging.

Primary outcomes

  1. Number of complications identified in data collection

    Time frame: Day 1

    Number of complications identified in data collection

Secondary outcomes

  1. Number of lesion identified in data collection

    Time frame: Day 1

    Number of lesion identified in data collection

Study contacts

Contact information is provided by the study sponsor or research team.

Sylvain GRANGE, MD

CONTACT

sylvain.grange@chu-st-étienne.fr

(0)477829066 ext. +33

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne

Other

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Sep 23, 2024
Registry last updated
Oct 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.